Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma.
Corona M, Ip A, Brown S, Luna A, Khatib H, Flynn JR, Devlin SM, Landego I, Cassanello G, Rejeski K, Zuckerman T, Dahi PB, Scordo M, Lin RJ, Kabat M, Luttwak E, Pavkovic E, Palomba ML, Park J, Salles G, Schoder H, Leithner D, Leslie LA, Perales MA, Beyar-Katz O, Shah GL, Shouval R. Corona M, et al. Among authors: beyar katz o. Bone Marrow Transplant. 2025 Feb 1. doi: 10.1038/s41409-025-02519-z. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 39893244
High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies.
Laham Y, Ringelstein-Harlev S, Kurnik D, Fineman R, Yehudai-Ofir D, Bonstein L, Setter-Marco N, Braun E, Ghersin I, Zuckerman T, Beyar-Katz O. Laham Y, et al. Among authors: beyar katz o. Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2024.286714. Online ahead of print. Haematologica. 2025. PMID: 39781629 Free article.
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.
Fadaos N, Dor YB, Azoulay T, Leiba R, Sharon-Horesh N, Levi T, Horowitz NA, Tzoran I, Lavi N, Beyar-Katz O, Dann EJ, Zuckerman T, Ringelstein-Harlev S. Fadaos N, et al. Among authors: beyar katz o. Ann Hematol. 2024 Dec;103(12):5861-5870. doi: 10.1007/s00277-024-06130-y. Epub 2024 Dec 12. Ann Hematol. 2024. PMID: 39663256
Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional Study.
Ram R, Amit O, Perry C, Herishanu Y, Avivi I, Sarid N, Apel A, Preis M, Aviv A, Shapira S, Shragai T, Joffe E, Shargian L, Herzog-Tsarfati K, Eylati N, Acria L, Fridberg G, Gold R, Glait-Santar C, Kay S, Gal-Rabinovich K, Rosenberg D, Setter-Marco N, Beyar-Katz O. Ram R, et al. Among authors: beyar katz o. Transplant Cell Ther. 2024 Dec;30(12):1178-1188. doi: 10.1016/j.jtct.2024.09.024. Epub 2024 Oct 11. Transplant Cell Ther. 2024. PMID: 39396632 Clinical Trial.
Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <I>de novo</I> large B-cell lymphoma and transformed low-grade B-cell lymphoma.
Benjamini O, Fried S, Shouval R, Flynn JR, Beyar-Katz O, Leslie LA, Zucherman T, Yerushalmi R, Shem-Tov N, Palomba ML, Danylesko I, Sdayoor I, Malka H, Itzhaki O, Suh H, Devlin SM, Marcus R, Dahi PB, Jacoby E, Shah GL, Sauter CS, Ip A, Perales MA, Nagler A, Shimoni A, Scordo M, Avigdor A. Benjamini O, et al. Among authors: beyar katz o. Haematologica. 2024 Nov 1;109(11):3566-3577. doi: 10.3324/haematol.2023.284664. Haematologica. 2024. PMID: 38899351 Free PMC article.
Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial.
Ram R, Amit O, Adler A, Bar-On Y, Beyar-Katz O, Avivi I, Shasha D, Ben-Ami R. Ram R, et al. Among authors: beyar katz o. Transplant Cell Ther. 2023 Nov;29(11):708.e1-708.e8. doi: 10.1016/j.jtct.2023.08.013. Epub 2023 Aug 15. Transplant Cell Ther. 2023. PMID: 37591446 Free article. Clinical Trial.
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Beyar Katz O, Perry C, Grisariu-Greenzaid S, Yehudai-Ofir D, Luttwak E, Avni B, Zuckerman T, Sdayoor I, Stepensky P, Ringelstein-Harlev S, Bar-On Y, Libster D, Sharvit L, Amit O, Greenbaum U, Gold R, Herishanu Y, Benyamini N, Avivi I, Ram R. Beyar Katz O, et al. Eur J Haematol. 2023 Jul;111(1):63-71. doi: 10.1111/ejh.13968. Epub 2023 Apr 10. Eur J Haematol. 2023. PMID: 36964939
36 results